News Shortcuts from other journals

New anticoagulant gets mixed results

BMJ 2007; 335 doi: (Published 20 September 2007) Cite this as: BMJ 2007;335:586

Idraparinux is a new anticoagulant that inhibits activated factor X. It has a long half life and can be given just once a week, by subcutaneous injection. But is it as good as standard anticoagulants at preventing recurrent venous thromboembolism? …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial